Malotilate - 10mM in DMSO , CAS No.59937-28-9

CAS: 59937-28-9 Cat. No.: M408468 Summenformel: C12H16O4S2 Molekulargewicht: 288.38
Zu bestellen verfügbar
QUALITÄT & REINHEIT 10mM in DMSO
Synonyms
NKK105|diisopropyl 2-(1,3-dithiol-2-ylidene)malonate
Storage
Store at -80°C
Shipped In
Dry ice packs + Cold packs
★
Größe
Deutschland (EU)
USA*
Preis
Menge
1ml
M408468-1ml
—
2 Auf Lager

208,17€

303,62€
Speichern 95,45 € (31.44%)
Enter a quantity for the sizes you want to add.

Übersicht

Information

Malotilate Malotilate (NKK105) is a drug used for the treatment of liver cirrhosis. Malotilate is a liver protein metabolism improved compound, which selectively inhibit the 5-lipoxygenase .
In vitro

Malotilate at concentrations of 0.1–100 μM increases collagenase activity in a concentration-dependent manner in the multilayered cultures, but not in the monolayers. Malotilate increases the secretion of MMP-1 and MMP-3 in the wounded multilayered cultures, but not in the wounded monolayers. Malotilate significantly reduces the invasion of the RLE monolayer by c-SST-2 cells. Malotilate prevents the increase in permeability of the RLE monolayer by serum starvation. Malotilate suppresses tumour metastasis by intensifying the cell-to-cell contact of endothelial cells, thus preventing tumour cells from invading vascular endothelium.

In vivo

Malotilate suppresses pulmonary metastasis and lung metastasis in rats. Malotilate prevents increases in serum markers of type III and IV collagen synthesis as well as accumulation of the collagens, laminin and fibronectin in the liver of rats. Malotilate combined with CCl4 significantly decreases hydroxyproline accumulation in the liver of rat, liver prolyl 4-hydroxylase and liver and serum galactosylhydroxylysyl glucosyltransferase activities. Malotilate is also able to prevent the development of morphological changes in the liver of rats such as focal necrosis, fatty infiltration and inflammatory changes. Malotilate also normalizes almost completely the standard liver-function tests. Malotilate decreases CYP2E1 levels and increases CYP2B1 levels in hepatic microsomes of rats, while CYP1A expression is not changed.
Cell Data

cell lines:HeLa, MCF7, MV4-11 and A2780 cells

Concentrations:

Incubation Time:

Powder Purity:≥99%

Spezifikationen

Synonyme
NKK105 | diisopropyl 2-(1,3-dithiol-2-ylidene)malonate
Spezifikationen & Reinheit
10mM in DMSO
Biochemische und physiologische Mechanismen
Malotilate (NKK105) is a drug used for the treatment of liver cirrhosis. Malotilate is a liver protein metabolism improved compound, which selectively inhibit the 5-lipoxygenase.
Storage
Store at -80°C
Verschickt in
Dry ice packs + Cold packs
Dieses Produkt erfordert Kühlkettenversand. Grundversand und andere Economy-Optionen sind nicht verfügbar.
Namen und Kennungen
Isomere SMILES
CC(C)OC(=O)C(=C1SC=CS1)C(=O)OC(C)C
RTECS
OO0970000
Molekulargewicht
288.38
Reaxys
7481938
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=7481938&ln=

Erweiterte Daten

Zertifikate (CoA, COO, BSE/TSE und Analyse-Diagramm)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Chemische und physikalische Eigenschaften
LöslichkeitSolubility (25°C) In vitro      
Schmelzpunkt (°C)61 °C
Sicherheit und Gefahren (GHS)
RTECS
OO0970000
Reaxys
7481938
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=7481938&ln=
Merck-Index
5712
Citations of This Product
Lösungsrechner
Bewertungen

Kundenbewertungen

Dürfen wir Sie über Rabattaktionen informieren?

Später erinnern

Vielen Dank! Bitte überprüfen Sie Ihren E-Mail-Posteingang, um zu bestätigen.

Hoppla! Benachrichtigungen sind deaktiviert.